Hansoh Pharmaceutical Group Company Limited
HNSPF
$5.20
$0.4910.40%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 3.21B | 3.34B | 3.23B | 3.25B | 3.51B |
Total Receivables | 447.18M | 465.33M | 404.36M | 406.95M | 464.70M |
Inventory | 89.22M | 92.84M | 82.50M | 83.03M | 81.20M |
Prepaid Expenses | 121.00K | 125.90K | -- | -- | 540.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 14.58M | 15.17M | 51.04M | 51.37M | 17.60M |
Total Current Assets | 3.76B | 3.91B | 3.77B | 3.80B | 4.07B |
|
|||||
Total Current Assets | 3.76B | 3.91B | 3.77B | 3.80B | 4.07B |
Net Property, Plant & Equipment | 444.87M | 462.92M | 455.28M | 458.21M | 462.53M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 33.61M | 34.97M | 27.06M | 27.23M | 25.02M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 2.92M | 3.04M | 2.41M | 2.43M | 1.96M |
Total Assets | 4.34B | 4.51B | 4.36B | 4.39B | 4.66B |
|
|||||
Total Accounts Payable | 29.85M | 31.06M | 24.02M | 24.18M | 23.09M |
Total Accrued Expenses | 286.30M | 297.92M | 282.72M | 284.54M | 277.72M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 7.79M | 8.11M | 7.64M | 7.69M | 592.21M |
Total Finance Division Other Current Liabilities | 45.31M | 47.15M | 157.97M | 158.99M | 74.81M |
Total Other Current Liabilities | 45.31M | 47.15M | 157.97M | 158.99M | 74.81M |
Total Current Liabilities | 369.25M | 384.24M | 472.36M | 475.39M | 967.84M |
|
|||||
Total Current Liabilities | 369.25M | 384.24M | 472.36M | 475.39M | 967.84M |
Long-Term Debt | -- | -- | -- | -- | 5.60M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 8.36M | 8.70M | 8.83M | 8.88M | 9.13M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 30.37M | 31.61M | 37.50M | 37.74M | 39.07M |
Total Liabilities | 407.99M | 424.54M | 518.68M | 522.01M | 1.02B |
|
|||||
Common Stock & APIC | 1.92B | 2.00B | 1.93B | 1.94B | 1.99B |
Retained Earnings | 1.91B | 1.98B | 1.84B | 1.85B | 1.61B |
Treasury Stock & Other | 104.37M | 108.61M | 74.52M | 75.00M | 41.50M |
Total Common Equity | 3.93B | 4.09B | 3.84B | 3.86B | 3.64B |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 3.93B | 4.09B | 3.84B | 3.86B | 3.64B |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 3.93B | 4.09B | 3.84B | 3.86B | 3.64B |
|